NASDAQ: CLLS
Cellectis Sa Stock Forecast, Predictions & Price Target

Analyst price target for CLLS

Based on 3 analysts offering 12 month price targets for Cellectis Sa

Min Forecast
$1.30+34.16%
Avg Forecast
$4.10+323.12%
Max Forecast
$8.00+725.59%

Should I buy or sell CLLS stock?

Based on 4 analysts offering ratings for Cellectis Sa.

Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 25%
Hold
2 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 25%

Be the first to know when Wall Street analysts revise their CLLS stock forecasts and price targets.

CLLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-16
lockedlocked$00.00+00.00%2026-09-15
lockedlocked$00.00+00.00%2026-09-15
lockedlocked$00.00+00.00%2026-09-15

1 of 1

CLLS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CLLS$0.99$4.10+314.14%Hold
OKYO$1.37$5.00+264.96%Buy
NTHI$2.77$17.00+513.72%Strong Buy
CRDF$0.93$5.50+490.76%Hold
PMN$8.09$47.80+490.85%Strong Buy

Cellectis Sa Stock Forecast FAQ

Is Cellectis Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CLLS) stock is to Hold CLLS stock.

Out of 4 analysts, 0 (0%) are recommending CLLS as a Strong Buy, 1 (25%) are recommending CLLS as a Buy, 2 (50%) are recommending CLLS as a Hold, 0 (0%) are recommending CLLS as a Sell, and 1 (25%) are recommending CLLS as a Strong Sell.

If you're new to stock investing, here's how to buy Cellectis Sa stock.

What is CLLS's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CLLS price target, the average CLLS price target is $4.10, with the highest CLLS stock price forecast at $8.00 and the lowest CLLS stock price forecast at $1.30.

On average, Wall Street analysts predict that Cellectis Sa's share price could reach $4.10 by Sep 16, 2027. The average Cellectis Sa stock price prediction forecasts a potential upside of 314.14% from the current CLLS share price of $0.99.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.